| Product Name: | Cinnarizine & Dimenhydrinate Tablets |
| Brand Name: | Generics |
| Strength: | (20mg+40mg) |
| Dosage Form: | Tablet (Un-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antiemetics, Aantihistamines. |
| Indication: | CINNARIZINE+DIMENHYDRINATE belongs to a group of anti-vertigo drugs used to treat the symptoms of vertigo such as dizziness, spinning sensation, nausea, and vomiting. Vertigo is a sudden external or internal spinning sensation that causes dizziness. It creates a false sense that you or your surroundings are moving or spinning. |
| Storage: | Store below 30˚C. Protect from Light and moisture |
GENERIC NAME OF THE MEDICINAL PRODUCT:
Cinnarizine & Dimenhydrinate Tablets 20mg+40mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Cinnarizine & Dimenhydrinate Tablets 20mg+40mg
Each Uncoated Tablet contains:
Cinnarizine IP.………………20mg
Dimenhydrinate BP.………………40mg
Excipients…………………………q.s.
Colour: Sunset Yellow
THERAPEUTIC INDICATIONS:
CINNARIZINE+DIMENHYDRINATE belongs to a group of anti-vertigo drugs used to treat the symptoms of vertigo such as dizziness, spinning sensation, nausea, and vomiting. Vertigo is a sudden external or internal spinning sensation that causes dizziness. It creates a false sense that you or your surroundings are moving or spinning.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SCHEDULE “H” Prescription Drug -Warning: it is Dangerous to take this preparation except under Medical Supervision.
STORAGE & DOSAGE:
Storage: Store below 30˚C. Protect from Light and moisture.
Dosage: As directed by the Physician.